Arthritis & Rheumatism · 1994 · 54 citations · 9 references
Life SciencesImmunologyMolecular BiologyAutoimmunityImmunopathologyRheumatologyAutoantibodiesAutoantigensAutoimmune Disease DiagnosticsAutoimmune DiseasesHistone ProteinsSystemic Lupus ErythematosusAnti-double-stranded Deoxyribonucleic Acid Antibody TestingAnti-double-stranded Dna AntibodiesAnti-histone AntibodiesAntibodiesAntinuclear Antibody PositivityAutoimmune SerologySystemic Lupus Erythematosus AssociationsSystemic Lupus Erythematosus Diagnostics
OBJECTIVE: To assess the role of antibodies to histones H2A, H2B, and anti-double-stranded DNA which form (H2A-H2B)-DNA complexes in patients with scleroderma-related disorders. METHODS: Antihistone antibodies were measured, by enzyme immunoassay, in 26 patients with scleroderma-related disorders, 100 patients with systemic lupus erythematosus (SLE), and 24 patients with rheumatoid arthritis. RESULTS: Antibodies to histone (H2A-H2B)-DNA complex were more commonly seen in patients with scleroderma-related disorders than in those with SLE (P < 0.0001). CONCLUSION: Scleroderma-related disorders should be included among conditions in which various types of antihistone antibodies are produced. A hypothesis to account for this finding is discussed.
9
The 1982 revised criteria for the classification of systemic lupus erythematosus
Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations
Antihistone Antibodies in Systemic Sclerosis
Shinichi Sato, Hironobu Ihn, Kanako Kikuchi et al. · Arthritis & Rheumatism · 1994 · 114 citations
Life Sciences, Immunology, Pathology +17
Antihistone antibodies in patients with localized scleroderma
Shinichi Sato, Hironobu Ihn, Yoshinao Soma et al. · Arthritis & Rheumatism · 1993 · 111 citations
Life Sciences, Immunology, Pathology +15